Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cadila Healthcare Ltd Approves Amalgamation


Monday, 22 Apr 2013 05:11am EDT 

Cadila Healthcare Ltd announced that Board of Directors of the Company and the Board of Directors of Zydus Animal Health Limited (ZAHL), Liva Healthcare Limited (LHL) and Zydus Pharmaceuticals Limited (ZPL) at their respective meetings held on April 22, 2013, approved the amalgamation of ZAHL, LHL and ZPL with the Company. In terms of the Scheme ZAHL, LHL and ZPL will be amalgamated with the Company followed by the dissolution without winding up of the ZAHL, LHL and ZPL. Upon the Scheme being effective, in consideration of the transfer and vesting of the undertaking of ZAHL, LHL and ZPL (the transferor Company) in the Company in terms of the Scheme, all the equity shares issued by the Transferor Companies and held by the Company and its nominees shall stand cancelled and extinguished and in lieu thereof, no allotment of any shares in the Company shall be made. Other terms of the transaction were not disclosed. 

Company Quote

1586.95
68.3 +4.50%
24 Dec 2014